Get started
ARGENX SE DRNARGENX SE DRNARGENX SE DRN

ARGENX SE DRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

A1RG34 chart


Full chart

Key stats


Market capitalization
‪232.24 B‬ BRL
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−19.418 BRL
Net income (FY)
‪−1.46 B‬ BRL
Revenue (FY)
‪6.09 B‬ BRL
Shares float
‪60.33 M‬
Beta (1Y)
0.00

About ARGENX SE


Sector
Health Technology
CEO
Tim van Hauwermeiren
Headquarters
Amsterdam
Website
argen-x.com
Founded
2008
ISIN
BRA1RGBDR004
FIGI
BBG00XX9HGJ7
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

A1RG34 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where A1RG34 is featured.

See all sparks